Alpha 2.0
Login Register
» Authors » Marek Gierlotka

Marek Gierlotka

Explore the profile of Marek Gierlotka including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 225
Citations 1321
Followers 0
Related Specialties
Cardiology & Vascular Diseases
General Medicine
Neurology
Top 10 Co-Authors
Mariusz Gasior
Lech Polonski
Michal Hawranek
Andrzej Lekston
Mateusz Tajstra
Krzysztof Wilczek
Zbigniew Kalarus
Marian Zembala
Wojciech Wojakowski
Tadeusz Osadnik
Published In
Kardiol Pol
Cardiol J
Postepy Kardiol Interwencyjnej
Pol Arch Intern Med
J Clin Med
Affiliations
Soon will be listed here.
Recent Articles
1.
ERRATUM: How and why to apply for grants? The position of the Expert Panel of the Committee on Science and Grants, Committee on Research and Scientific Analysis, and Club 30 of the Polish Cardiac Society
Tajstra M, Pyka L, Cieplucha A, Danilowicz-Szymanowicz L, Gasior P, Gierlotka M, et al.
Kardiol Pol . 2025 Mar; 83(2):256. PMID: 40066969
No abstract available.
2.
Interdisciplinary expert team statement on the treatment of multi-bed atherosclerotic disease - endorsed by Polish Cardiac Society, Polish Lipid Association, Polish Society of Diabetology, Polish Neurological Society, Polish Society of Nephrology
Dyrbus K, Banach M, Gil R, Gasior M, Broncel M, Gellert R, et al.
Kardiol Pol . 2025 Mar; PMID: 40066957
Atherosclerosis is a systemic disease and involves not only the coronary vessels but also occurs in other vascular beds (e.g., cervical, cerebral, and peripheral vessels), increasing cardiovascular risk. One of...
3.
Correction to "Impact of surrogates for insulin resistance on mortality and life expectancy in primary care: a nationwide cross-sectional study with registry linkage (LIPIDOGRAM2015)" [The Lancet Regional Health - Europe 49 (2025) 101182]
Chen Y, Zhong Z, Gue Y, Banach M, McDowell G, Mikhailidis D, et al.
Lancet Reg Health Eur . 2025 Mar; 50:101245. PMID: 40046687
[This corrects the article DOI: 10.1016/j.lanepe.2024.101182.].
4.
Percutaneous coronary intervention and coronary artery bypass grafting in myocardial infarction complicated by cardiogenic shock
Gasior M, Tajstra M, Deja M, Gil R, Pacholewicz J, Bartus S, et al.
Kardiol Pol . 2025 Feb; PMID: 39976500
Background: Cardiogenic shock (CS) remains the leading cause of poor prognosis in patients with acute myocardial infarction (AMI), sustaining a high mortality rate of 40 to 50% within 30 days....
5.
Use of FGF-23 and sαKlotho for Risk Stratification in Patients with Acute Heart Failure
Plonka J, Olejnik A, Klus A, Gawrylak-Dryja E, Wezyk N, Rzepiela L, et al.
J Clin Med . 2025 Feb; 14(3). PMID: 39941530
Soluble αKlotho (sαKlotho) and fibroblast growth factor 23 (FGF-23) are increased in acute heart failure (AHF). This study aimed to assess changes in serum sαKlotho and FGF-23 concentrations during an...
6.
Wearable cardioverter-defibrillator use in clinical settings in Poland: Nationwide observational cohort study
Sterlinski M, Przybylski A, Grabowski M, Kempa M, Kazmierczak J, Mitkowski P, et al.
Kardiol Pol . 2025 Feb; PMID: 39932376
No abstract available.
7.
Sex differences in patients with working diagnosis of myocardial infarction with nonobstructive coronary arteries (MINOCA)
Milewski M, Desperak A, Kozlik M, Bujak M, Gierlotka M, Milewski K, et al.
Sci Rep . 2025 Jan; 15(1):2764. PMID: 39843545
Myocardial infarction with nonobstructive coronary arteries (MINOCA) constitutes 3-15% of all acute myocardial infarctions. Women are more frequently diagnosed with MINOCA, although the influence of sex on long-term outcomes is...
8.
Management of patients with acute myocardial infarction treated between 2019-2022 with 12-month follow-up: Data from comprehensive all-comers administrative database covering a whole population of Poland
Tajstra M, Wilczek K, Witkowski A, Wita K, Stepinska J, Wojakowski W, et al.
Kardiol Pol . 2025 Jan; PMID: 39835678
No abstract available.
9.
Hybrid coronary revascularization in multivessel disease: Long-term clinical outcomes of a prospective randomized study
Tajstra M, Zembala M, Gierlotka M, Filipiak K, Gasior M, Hrapkowicz T, et al.
Kardiol Pol . 2025 Jan; 82(12):1278-1280. PMID: 39775558
No abstract available.
10.
Impact of surrogates for insulin resistance on mortality and life expectancy in primary care: a nationwide cross-sectional study with registry linkage (LIPIDOGRAM2015)
Chen Y, Zhong Z, Gue Y, Banach M, McDowell G, Mikhailidis D, et al.
Lancet Reg Health Eur . 2025 Jan; 49:101182. PMID: 39759579
Background: Insulin resistance (IR) is an important risk factor for multiple chronic diseases, increasing mortality and reducing life expectancy. The associations between emerging surrogates for IR, triglyceride-glucose index (TyG) and...